Associations between male infertility and cancer are gaining clinical attention. Relationships between infertility and cancer have traditionally been studied in women, but recent work has focused on the male component of reproduction. Infertile men are at an elevated risk to develop various malignancies later in life, primarily genitourinary malignancies such as testicular and prostate cancer. Rates of testicular and high-grade prostate cancer in infertile men appear to be at least double the risk in the general population. The link between infertility and malignancy highlights the importance of thorough evaluation and long-term follow up-beyond a simple semen analysis. A detailed urologic evaluation, possibly including scrotal ultrasound, may be beneficial to screen infertile men for testicular cancer. Publications have also demonstrated that male infertility can be a biomarker for cancer risk in first-and second-degree relatives. Testicular cancer risk in first-degree relatives of infertile men is 52% higher than the risk in relatives of fertile control men, and male infertility has been associated with a two-to threefold elevation in risk of childhood cancer in the siblings of infertile men. Links between infertility and malignancy are multifactorial, and exact mechanistic explanations are still not fully understood. Although more studies are needed to assess levels of risk and create screening recommendations in this population, understanding the relationship between male infertility and malignancy is crucial to provide comprehensive counseling for infertile men and their families.
M
ale-factor infertility is extremely common. In the United States, 15% of couples report infertility, and a male component is thought to be a contributing factor in up to 50% of infertility cases (1) . Approximately 7.5% of American men have undergone semen analysis at an assisted reproduction center as part of a fertility evaluation, and each year nearly 700,000 men pursue an evaluation for male-factor infertility in the United States (2, 3) . There is a growing body of literature demonstrating that both male and female infertility may be associated with long-term health consequences, including an elevated risk of malignancy (4) (5) (6) (7) . Historically, research has focused on the overall health of the female partner during an infertility evaluation. Strong correlations have been documented between female infertility and certain types of cancer, but comparatively less is known about the risk of malignancy in infertile men (6, 8) .
One of the challenges that researchers face when evaluating associations between male infertility and malignancy risk is the severe lack of centralized data related to male infertility. Large-scale databases, such as the Society for Assisted Reproductive Technology (SART) clinical summary report and the National ART [assisted reproductive technology] Surveillance System (NASS) published by the Centers for Disease Control and Prevention (CDC), are not specifically designed to include important information about male-factor infertility. In addition, cancer databases, such as the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, have a wealth of information regarding malignancy, but this information is not tied to infertility. Evaluating both individual and familial health risks associated with a diagnosis of male infertility becomes logistically difficult when data are scarce. Databases such as the National Survey of Family Growth (NSFG) and the Reproductive Medicine Network do collect some data regarding male infertility, but those databases were originally designed for women, making their application to male-factor infertility less than ideal. The Andrology Research Consortium database was built for the purpose of collecting data about malefactor infertility, but currently there are relatively limited data available from that source. Large populationlevel databases such as the Truven Health Marketscan and the Utah Population Database have proven to be useful in performing retrospective cohort studies looking at male infertility, but similarly to most other databases, they were not specifically designed to collect data related to male infertility. Using existing databases to determine an exact cause for infertility is also relatively more difficult in men than in women, and in the setting of idiopathic male-factor infertility, identifying causal relationships between infertility and health comorbidities can be problematic (9) .
Until recently, publications within the medical literature have placed less emphasis on the male component of reproduction and possible associations between male infertility and malignancy (10) . Although it is understood that treatment for cancer may negatively affect one's fertility, it is becoming increasingly clear that male-factor infertility may play an important role in the overall health status of men, and that men with infertility may be at an increased risk to develop incident testicular cancer, prostate cancer, non-Hodgkin lymphoma, leukemia, melanoma, and other types of malignancy (7, 11, 12) . In addition, recent work has proposed that male infertility may be not only a biomarker of the overall health status of the infertile patient but also a marker of the health status and malignancy risk for family members (3, 13, 14) . Molecular, environmental, and genetic factors linking male infertility to malignancy have been suggested, and there are increasing data to support specific mechanisms that predispose men to both infertility and malignancy. The hypothesis that male infertility may be a harbinger of certain types of malignancy, such as testicular cancer, is gaining clinical acceptance (15) . In the following review, no Institutional Review Board approval was necessary.
CANCER RISK AMONG INFERTILE MEN Testis Cancer
One of the most well documented associations between male infertility and malignancy is seen with testicular cancer. In some ways, this is not surprising, given that spermatogenesis and testicular tumors are both some of the highestthroughput processes in the human body in the benign and malignant states, respectively. Both infertility and testicular cancer are often diagnosed at a relatively young age, with the average age at testicular cancer diagnosis being 33 years. For the general male population in the United States, the lifetime risk of testicular cancer is about 1 in 263 (16) . The vast majority of testicular cancers are of germ cell origin (98%) (17) . Although testicular cancer represents only 1% of malignancies in men, it is the most common cancer diagnosed in young men aged 15-34 years (17, 18) . The overall prevalence of testicular cancer in the United States is 4.84 per 100,000 men and 1 in 100,000 for black men (19) . Globally, the incidence of testicular cancer appears to be increasing, although mortality related to this malignancy has declined in Western countries in recent decades (17) . Owing to successful treatments, a man's lifetime risk of dying from testicular cancer is low, 1 in 5,000 (16) .
Various explanations have been proposed for the link between male infertility and testicular cancer because there appears to be a strong epidemiologic and biologic connection between these two disease processes (18) . Consistently, significant elevations in rates of testicular cancer are seen among men with infertility and poor semen quality. Multiple studies have evaluated specific rates of testicular cancer among infertile male populations (Table 1) . Specific elevations in testicular cancer risk vary depending on the publication, from a twofold elevation in risk seen in a large study of United States claims data to >20 times higher risk in a retrospective cohort study of 3,847 infertile men who were compared with a baseline healthy population (5, 7, (20) (21) (22) (23) (24) . A large retrospective cohort study from the Utah Population Database of 20,433 men undergoing semen analysis demonstrated elevated risk of testicular cancer in men with oligozoospermia based on concentration (hazard ratio [HR] 11.9) and sperm count (HR 10.3). Men in the lowest quartile of motility, viability, morphology, or total motile count were also found to have higher risk of testicular cancer (20) . One large study evaluating 2,179 healthy, young military recruits found no cases of testicular cancer with the use of scrotal ultrasound for screening, whereas pooled data from infertile men who underwent similar scrotal ultrasound screening showed a testicular cancer incidence of 0.5% (18, 25) . The finding of scrotal masses in the infertile male population is not uncommon, and although most of these masses are benign and can be safely followed with surveillance, the recommendation for routine use of scrotal ultrasound in men with infertility is worth considering owing to the relatively frequent finding of malignancy at the time of an infertility consultation (25) (26) (27) . Compared with physical examination, ultrasound appears to be a superior means to detect testicular abnormalities. In a study by Pierik et al., 67% of ultrasound findings were not evident on palpation, and only one out of seven testicular tumors were identified by physical exam alone (25) . At this time, there is insufficient evidence to advocate the routine use of scrotal ultrasound in all infertile men, although ultrasound could be beneficial if future evidence supports its cost effectiveness.
The connection between male infertility and testicular cancer is likely multifactorial, with a combination of hormonal, genetic, in utero, and environmental factors contributing to the development of testicular cancer in the infertile population (17) . Figure 1 details possible mechanistic links between male infertility and testicular cancer. High estrogen levels in utero may contribute to the development of this malignancy. Hormonal disruptions during embryologic development may disrupt normal modulation of primordial germ cells as well as mesenchymal and Sertoli cell differentiation, leading to later problems related to steroidogenesis and spermatogenesis (e.g., testicular dysgenesis syndrome) (18, 28, 29) . Abnormalities in these pathways may result in a predisposition to both infertility and testicular cancer.
Testicular abnormalities such as cryptorchidism are a known risk factor for the development of testicular malignancy, with relative risk elevations ranging from four to nine (23) . Cryptorchidism is also strongly associated with infertility and is one of the most common etiologies for azoospermia in adults (30) . The prevalence of cryptorchidism in full-term male infants is 1%-3% but has been reported to be as high as 30% in premature male infants (31) . Despite improvements in fertility outcomes for adult men who have undergone surgical correction of cryptorchidism as infants, subfertility as an adult remains a concern. After surgery, 80% of adult men with a history of bilateral cryptorchidism and 30% of men with a history of unilateral cryptorchidism have abnormal sperm counts (32) . Abnormal testicular development and dysregulation of expression of growth factors seen in cryptorchid males may contribute to both subsequent infertility as well as testicular cancer risk (33) . From 20% to 30% of male infertility is thought to be caused by genetic defects, and some of these genetic changes may also play a role in the development of testicular cancer. The possibility of an underlying genetic component to the link between male infertility and testicular cancer is highlighted by epidemiologic studies suggesting that the brothers of men with testicular cancer may also have decreased fertility and be at an elevated risk of developing testicular cancer (18, 34) . Several unknown moderate risk genes may explain some of the inherited susceptibility seen with testicular cancer and may also have a detrimental impact on male fertility (35) .
Environmental factors, such as smoking, may predispose men to both infertility and testicular cancer. Smoking has been proposed in certain studies as a risk factor for testicular cancer, and men who smoke have been shown to have higher rates of erectile dysfunction, elevations in chromosomally abnormal sperm, and decreased sperm concentration, motility, and morphology (36) (37) (38) . Interestingly, in a study from Canada both former and current smokers appeared to be at an elevated risk of developing testicular cancer, suggesting that the effect of smoking cessation on decreasing the subsequent development of testicular cancer may be minimal (39) . However, not all publications support the connection between tobacco use and testicular cancer. A recent Italian study reported no apparent association between alcohol or tobacco use during adolescence (ages 13-19 years) and later diagnoses of testicular cancer (40) . Maternal smoking during pregnancy may lead to elevated rates of cryptorchidism in male offspring, which is a known risk factor for the future development of testicular cancer. Male offspring who were exposed to tobacco in utero may also suffer from impaired semen quality in adulthood, although the influence on fecundability is less clear (41) . Although smoking and other environmental or occupational exposures may have a negative health impact with detrimental effects on fertility, the relationships between tobacco use, environmental exposures, and testicular cancer are not entirely clear from a mechanistic standpoint.
Prostate Cancer
A significant amount of recent data is also available regarding associations between male infertility and prostate cancer, although the relationship between infertility and
FIGURE 1
Potential mechanisms between male infertility and testicular cancer. (20) . In addition, a nested case-control study in Sweden reported a lower odds of prostate cancer in men with a history of male infertility (43) . Importantly, in studies demonstrating an association between infertility and prostate cancer, there appears to be a significant chronologic separation between a diagnosis of infertility and a diagnosis of prostate cancer. A diagnosis of infertility in a man's fourth decade of life appears to confer an elevated risk of prostate cancer in his sixth decade (44) . Several studies using large databases have used fatherhood status as a proxy for male infertility and evaluated the relationship between fatherhood and a subsequent prostate cancer diagnosis (5, (45) (46) (47) . A large meta-analysis from 2016 provided a summary of 11 publications that examined prostate cancer risk based on fatherhood status. Overall, a pooled analysis suggested a decreased risk of prostate cancer in childless men (odds ratio [OR] 0.91, 95% CI 0.87-0.96) (48) . The authors hypothesized that childless men may lie at a lower androgen state and thus would be at lower risk for prostate cancer. It should be noted that fatherhood status is an imperfect marker of infertility, making it difficult to directly apply conclusions from these publications to the infertile population.
Mechanisms linking prostate cancer to male infertility remain largely hypothetic, and, given the somewhat conflicting nature of current data, identifying a causal relationship between these two disease processes remains a challenge. Theories involving environmental modulators, genetic influences, and hormonal function that have been proposed to explain associations between infertility and testicular cancer have been extrapolated to prostate cancer as well (44) . With abnormal gonadal function, the prostate may receive aberrant signals during key phases of development which could result in an elevated risk of malignancy. In addition, variations in CAG repeats in the gene encoding the androgen receptor or problems with DNA mismatch repair may have implications for both male infertility and prostate cancer (44) . 
Other Cancers
Compared with testicular cancer and prostate cancer, much less is known about the associations between male infertility and other types of cancer (Table 3) . Until a few years ago, research in this area was nonexistent, so trends are only beginning to emerge that link male infertility to malignancies outside of the genitourinary tract. . However, the risks of several malignancies were also elevated for the control groups. With the use of internal comparisons, the group concluded that men with male infertility had higher risks of testis cancer, non-Hodgkin lymphoma, and all cancers. In the same study, infertile men had a 49% higher overall cancer risk compared with control men (7). A similar study performed in Texas demonstrated that in a population of 22,089 men who underwent semen analysis, azoospermic men had a significantly elevated risk of any cancer diagnosis (SIR 2.9, 95% CI 1.4-5.4). There was also a nonsignificant trend toward higher rates of cancer in nonazoospermic men who had been diagnosed with male-factor infertility (SIR 1.4, 95% CI 0.9-2.2) (49). Interestingly, a Utah study of 20,433 men undergoing semen analysis demonstrated a doubling of the risk of melanoma in men within the highest quartile of total motile sperm count (HR 2.0, 95% CI 1.0-3.87), which would contradict the proposed association between melanoma and poor semen parameters. That population database study also demonstrated a trend toward increased risk of any cancer with decreasing sperm motility (HR 1.19, 95% CI 1.1-1.4), but no elevated risk of malignancy was noted related to changes in morphology, viability, or total motile counts (20) .
Aside from testicular cancer and prostate cancer, reported associations between male infertility and other types of cancer are relatively scarce. Other groups have failed to identify any non-germ cell tumors among infertile men (21) . There is a paucity of literature linking male infertility to many types of cancer, and a causal relationship between infertility and cancer remains uncertain (7). However, common biologic mechanisms may underlie many associations between subfertility and cancer risk. Because a significant percentage of the male genome is involved with reproduction, genetic abnormalities may lead to adverse reproductive health as well as future malignancies (50) . Fetal exposures or environmental factors, such as tobacco smoking, may also predispose men to subfertility and can lead to elevated risk of various malignancies, such as lung cancer and bladder cancer, in the future (51) . Although the association between testicular cancer and male infertility has been well studied, associations between infertility and other types of cancer continue to emerge. Studies to confirm these associations and describe possible causal pathways are crucial going forward. 
FAMILIAL CANCER RISK
An infertility diagnosis in a man appears to carry health consequences for that individual, but data increasingly demonstrate that infertility may also be a biomarker of health for the infertile man's family members (Table 4) . A study published in 2016 evaluated 12,889 men who underwent semen analysis and 12,889 fertile control men. That study evaluated the risks of a generalized diagnosis of any cancer as well as specific cancer risks for testicular cancer, thyroid cancer, breast cancer, prostate cancer, melanoma, bladder cancer, ovarian cancer, and kidney cancer were evaluated among first-and second-degree relatives. It demonstrated that the first-degree relatives of men who underwent semen analysis for an infertility evaluation had a 52% increased risk of testicular cancer compared with first-degree relatives of fertile control men. Second-degree relatives did not appear to have an elevated testicular cancer risk. In addition, first-and second-degree relatives of azoospermic men were found to have a significantly increased risk of thyroid cancer compared with fertile control men (3). Another study evaluating the siblings and cousins of 10,511 men in Utah who underwent complete semen analysis demonstrated a twofold increased risk of any childhood cancer (HR 2.09, 95% CI 1.18-3.69) and a threefold increased risk of acute lymphoblastic leukemia (HR 3.07, 95% CI 1.11-8.46) in the siblings of subfertile men compared with fertile control men. That study found that the three most common types of cancer diagnosed in the siblings of men with abnormal semen parameters were acute lymphoblastic leukemia, brain cancer, and Hodgkin lymphoma (13) . Aside from those studies, data evaluating the risk of malignancy in family members of infertile men are essentially absent. Overall, very few studies have evaluated the risk of malignancy in the family members of infertile men. Shared genetics or environmental exposures provide plausible mechanisms. Given the trend toward elevated risk of various malignancies in first-and second-degree relatives of infertile men in the existing data, this appears to be an area of particular importance for future research.
DISCUSSION
Male infertility is heterogeneous, complex, and often multifactorial. The exact cause of male infertility is frequently unknown, with 40%-50% of male-factor infertility cases classified as idiopathic or unexplained (52) . Similarly, associations between infertile men, their family members, and incident cancer are poorly understood. To date, specific causal mechanisms relating infertility to malignancy are lacking. Nevertheless, strong evidence is emerging to support the idea that men with infertility are at an increased risk of developing various malignancies. Figure 2 highlights the specific malignancies associated with infertile men and their family members. A more thorough understanding of the impact of genetics and epigenetics on infertility will likely elucidate mechanistic pathways that connect infertility to cancer.
More than 1,500 genes are thought to contribute to spermatogenesis alone, so it is plausible that defects in any of these genes may also be tied to the development of cancers of the reproductive system as well as other organ systems (3, 53, 54) . Genetic defects resulting in male infertility and cancer may also provide an explanation for elevated risks of cancer seen in the family members of infertile men (34, 35) . Furthermore, DNA mismatch repair defects also
FIGURE 2
Specific malignancies associated with infertile men and their family members by average age at diagnosis. represent a promising new avenue of investigation that could potentially link the mechanisms of male infertility and oncogenesis (55) (56) (57) .
Specific cancer risks may be related to underlying genetic, epigenetic, environmental, and hormonal causes of male infertility. As these associations become clear, it will be important to determine if there are subsets of infertile men who are predisposed to particular malignancies. In addition, clarifying the chronologic separation between the time of an infertility diagnosis and the presence of specific malignancies will allow for more thorough counseling of infertile patients. Associations between infertility and malignancy have important implications for overall health, and having an understanding of these associated disease processes is paramount to comprehensive care in the infertile population.
CONCLUSION
The strongest and most studied relationship between male infertility and malignancy is that with testicular cancer, in both infertile men themselves and their relatives (5, 7, (20) (21) (22) (23) (24) ). There appears to be a direct relationship between male infertility and the development of high-grade prostate cancer, although data do not consistently support that association and studies of fatherhood seem to suggest that being childless may decrease a man's risk of developing prostate cancer (5, 7, 20, 42, (44) (45) (46) (47) (48) . Relatively less is known about the risk of subfertile men developing other types of cancer, although elevations in rates of melanoma, bladder cancer, thyroid cancer, Hodgkin lymphoma, non-Hodgkin lymphoma, and leukemia have been noted (7) . Further research regarding cancer risk in the family members of infertile men is necessary to better understand the implications of a male infertility diagnosis (3, 13, 14) .
